Printer Friendly Version  View printer-friendly version
<< Back
Array BioPharma To Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2004 on August 2, 2004

BOULDER, Colo.--(BUSINESS WIRE)--July 27, 2004--Array BioPharma Inc. (Nasdaq:ARRY) will report financial results for the fourth quarter and full year of fiscal 2004 on Monday, August 2, 2004, at 4:30 p.m. eastern time and hold a conference call on Tuesday, August 3, 2004, at 9:00 a.m. eastern time. Robert E. Conway, Chief Executive Officer, and Michael Carruthers, Chief Financial Officer, will lead the call.

Date:        Tuesday, August 3, 2004
Time:        9:00 a.m. eastern time
Toll-Free:   (800) 946-0719
Toll:        (719) 457-2645
Pass Code:   661325
Web Cast:

There will be a replay of the conference call for one week, which can be accessed in the United States by dialing toll-free (888) 203-1112, and outside the United States (719) 457-0820. The access code is 661325. Replay of the call will also be available as a web cast on Array's web site at

Array BioPharma is a biopharmaceutical company focused on the discovery, development and commercialization of orally active drugs to address significant unmet medical needs. Our proprietary drug development pipeline is primarily focused on the treatment of cancer and inflammatory disease and includes several small molecule drug candidates that are designed to regulate targets in therapeutically important biologic pathways. In addition, leading pharmaceutical and biotechnology companies access our drug discovery technologies and expertise through collaborations to design, create, optimize and evaluate drug candidates across a broad range of therapeutic areas. For more information on Array, please go to

Array BioPharma Inc.
Tricia Haugeto, 303-386-1193

Array BioPharma Inc.
ShareThis Copy and Paste